Alberta’s health minister has reached a tentative deal that will allow provinces to cover the costs of an expensive cystic fibrosis drug a year after a 12-year-old Ontario girl lobbied for the funding.

Alberta-led negotiations on behalf of all provinces to get Boston-based Vertex Pharmaceuticals Inc. to sell them Kalydeco at a price that they could afford to pay on their drug plans. The drug treats symptoms of a rare kind of cystic fibrosis, an incurable and fatal disease that fills the lungs with thick, sticky mucus.

For more details, go to: http://www.theglobeandmail.com/life/health-and-fitness/health/provinces-to-cover-costs-of-cystic-fibrosis-drug/article18936089/